Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
December 3, 2024
Loading feed metadata...
Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet
Sign up